Prosecution Insights
Last updated: August 13, 2026
Application No. 18/842,795

SURFACE-TREATED ZINC OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC MATERIAL, METHOD FOR PRODUCING SURFACE-TREATED ZINC OXIDE PARTICLES

Non-Final OA §103
Filed
Aug 29, 2024
Priority
Apr 27, 2022 — JP 2022-073189 +1 more
Examiner
JANOSKO, CHASITY PAIGE
Art Unit
Tech Center
Assignee
Sumitomo Osaka Cement Co., Ltd.
OA Round
1 (Non-Final)
18%
Grant Probability
At Risk
1-2
OA Rounds
1y 5m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants only 18% of cases
18%
Career Allowance Rate
7 granted / 40 resolved
-42.5% vs TC avg
Strong +78% interview lift
Without
With
+77.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
45 currently pending
Career history
102
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
52.8%
+12.8% vs TC avg
§102
4.9%
-35.1% vs TC avg
§112
32.3%
-7.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 40 resolved cases

Office Action

§103
DETAILED ACTION Status of the Application The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 3-5 are withdrawn. Claims 1-2 are pending and represent all claims currently under consideration. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Should applicant desire to obtain the benefit of foreign priority under 35 U.S.C. 119(a)-(d) prior to declaration of an interference, a certified English translation of the foreign application must be submitted in reply to this action. 37 CFR 41.154(b) and 41.202(e). Failure to provide a certified translation may result in no benefit being accorded for the non-English application. Claims 1-2 are considered to have an effective filing date of 04/25/2023. Election/Restrictions Applicant's election with traverse of Group I in the reply filed on 07/21/2026 is acknowledged. The traversal is on the ground(s) that Sunao teaches wet surface treatment using water or organic solvents, which inherently necessitates a subsequent solvent-removal or drying step that causes aggregation of particles, and that such configuration is different from the special technical feature of claim 1. Further, Applicant states that Sunao fails to teach or suggest to optimize the content of the surface treatment agent and control the particle size distribution for a specific particle diameter D98 value (Remarks, pages 4-5). This is not found persuasive because there is no limitation in the claims restricting the surface treatment from being a wet surface treatment or from having solvent-removal or drying step, and Sunao teaches both a dry and wet treatment method (Sunao, page 9), and a surface treatment agent and dry particle diameter D98 as claimed, as stated in the rejection below. The requirement is still deemed proper and is therefore made FINAL. Claims 3-5 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on 07/21/2026. Information Disclosure Statement The information disclosure statements filed 08/29/2024 and 09/16/2025 have been considered. Specification The use of the terms Mastersizer and Silquest, which are trade names or marks used in commerce, has been noted in this application. The term should be accompanied by the generic terminology; furthermore the term should be capitalized wherever it appears or, where appropriate, include a proper symbol indicating use in commerce such as ™, SM , or ® following the term. Although the use of trade names and marks used in commerce (i.e., trademarks, service marks, certification marks, and collective marks) are permissible in patent applications, the proprietary nature of the marks should be respected and every effort made to prevent their use in any manner which might adversely affect their validity as commercial marks. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-2 are rejected under 35 U.S.C. 103 as being unpatentable over Sunao (JP 2021160953 A; IDS reference, 08/29/2024), further in view of Hayashi (WO 2016190399 A1; IDS reference, 08/29/2024). Sunao was cited previously by the Examiner. Regarding claim 1, Sunao teaches metal oxide particles surface treated with an alkoxysilane (Sunao, claim 1), wherein the metal oxide can be zinc oxide (Sunao, page 7, 2nd paragraph), the BET specific surface area is 1.5 m2/g or higher and preferably less than 8 m2/g (Sunao, page 7, 3rd paragraph), and a D98 is 500 micrometers or less, which encompasses the claimed range (Sunao, page 16, example 1). Sunao specifies the D98 is the cumulative volume percentage of the powder (i.e., dry) particle size (Sunao, page 6, 3rd paragraph). Sunao further teaches the alkoxysilane can be octyltrimethoxysilane or octyltriethoxysilane (i.e., alkylalkoxysilanes having an alkyl group having 8 carbon atoms; Sunao, page 8, 5th paragraph). Sunao does not specify a content percentage of the surface treatment agent as claimed. Hayashi, however, teaches zinc oxide surface treated with triethoxycaprylylsilane (i.e., octyltriethoxysilane as defined by the instant specification, page 25, paragraph 0044) in 0.5-10 parts by weight (Hayashi, page 5), which encompasses the claimed range of 0.70-0.92% by mass. In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. See MPEP §2144.05(I). Sunao and Hayashi are considered to be analogous to the claimed invention, because Sunao, Hayashi, and the instant invention are in the same field of surface treated zinc oxide particles in cosmetics. It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the teachings of Sunao to use octyltriethoxysilane in the amount taught by Hayashi, because both teach the same surface treatment of the same particles, while Hayashi teaches the amount as claimed is a sebum absorbent with high UV shielding ability (Hayashi, page 5). Regarding claim 2, Sunao and Hayashi together teach all the elements of the current invention as applied to claim 1. As above, Sunao teaches the particles surface treated with an alkoxysilane (Sunao, claim 1), which can be octyltrimethoxysilane or octyltriethoxysilane (Sunao, page 8, 5th paragraph). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHASITY P JANOSKO whose telephone number is (703)756-5307. The examiner can normally be reached 7:30-3:30 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Brian-Yong Kwon can be reached at (571)272-0581. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /C.P.J./Examiner, Art Unit 1613 /JENNIFER A BERRIOS/ Primary Examiner, Art Unit 1613
Read full office action

Prosecution Timeline

Aug 29, 2024
Application Filed
Aug 05, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12642774
METHOD FOR PRODUCING A CORE-SHELL CAPSULE FOR DELIVERING A THERAPEUTIC AGENT
3y 4m to grant Granted Jun 02, 2026
Patent 12616207
BOXWOOD ENDOPHYTE BURKHOLDERIA SP SSG AS POTENTIAL BIOCONTROL AGENT AGAINST A WIDE RANGE OF PATHOGENS
3y 8m to grant Granted May 05, 2026
Patent 12605329
CLEANSING PREPARATION CONTAINING CAESALPINIA SPINOSA GUM
4y 0m to grant Granted Apr 21, 2026
Patent 12409114
CLEANSING/SANITIZER COMPOSITIONS, METHODS AND APPLICATIONS THEREOF
3y 10m to grant Granted Sep 09, 2025
Patent 12239703
COMPOSITE-TYPE NANO-VACCINE PARTICLE
2y 9m to grant Granted Mar 04, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
18%
Grant Probability
95%
With Interview (+77.8%)
3y 4m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 40 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month